potential indications for glp-1 receptor agonists keep expanding Diabetes vs GLP-1 for Weight Loss: What's Changing for Patients and Pharmacies? The expanding scope of GLP-1

Additional information Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Patients typically experience reductions in HbA1c (glycated haemoglobin) of approximately 1.01.5% (1116 mmol/mol) when added to existing therapy, with some agents achieving even greater reductions

Which Is Better: Tirzepatide vs Semaglutide: Both compounds are excellent, but the best choice depends on your goal, risk profile, and access

More than ten medications are already FDA approved for weight loss

Makary, M

Include them in a balanced multivitamin rather than standalone high-dose products